Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 3Urinary Bladder Neoplasms 1Nasopharyngeal Carcinoma 1Epstein-Barr Virus Infections 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 15Fluorouracil 13Bevacizumab 13Leucovorin 10Capecitabine 8Folfox protocol 7Irinotecan 6IFL protocol 4Cetuximab 4Folic Acid 3Aspirin 3atezolizumab 2XELOX 2Surgical Procedures, Operative 2Magnetic Resonance Spectroscopy 2Drug Therapy 2Chemotherapy, Adjuvant 2trifluridine tipiracil drug combination 1trametinib 1titanium silicide 1sulindac sulfone 1spartalizumab 1sacituzumab govitecan 1regorafenib 1raltitrexed 1pertuzumab 1irinotecan sucrosofate 1folfirinox 1envafolimab 1dabrafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2/3 × Colorectal Neoplasms × Watchful Waiting × Clear all
NCT01097265 2013-08-12

Study of Micrometastases in Patients With Stage I or Stage II Localized Colon Cancer That Can Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2/3 Unknown
1,500 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡